Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Institut Paoli-Calmettes1 site in 1 country5,000 target enrollmentOctober 15, 1999

ConditionsBreast Cancers Ovarian Cancers

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Cancers
Sponsor: Institut Paoli-Calmettes
Enrollment: 5000
Locations: 1
Primary Endpoint: Incidence of breast and / or ovarian cancer during subject lifetime
Status: Recruiting
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Detailed Description

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Registry

clinicaltrials.gov

Start Date

October 15, 1999

End Date

October 15, 2028

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Institut Paoli-Calmettes

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•A person of legal age subject to a legal protection measure, or unable to express consent.
•Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons

Outcomes

Primary Outcomes

Incidence of breast and / or ovarian cancer during subject lifetime

Time Frame: 10 years

risk that a subject with a mutation develops breast and / or ovarian cancer during his lifetime, assessed by epidemiologic questionnaires (carcinologic events).